Delivery Order SPE2DB24D1107-SPE2DB25FZGL8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a $2,769.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count) on August 29, 2025, with completion targeted for September 2, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. SUNOSI (solriamfetol) is a wakefulness-promoting agent primarily prescribed for narcolepsy and obstructive sleep...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count units) valued at $1,015.43 under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by August 13, 2025. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy and other sleep disorders. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,978.98 for SUNOSI 150 mg tablets (30-count) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a $1,881.03 delivery order to AmerisourceBergen Drug Corp for Sunosi 75 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count units) under a firm fixed-price contract valued at $4,769.02. This non-set-aside competitive award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Sunosi 75 mg tablets (30-count package) with a firm fixed price ceiling value of $3,765.50 and an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.77 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $3,058.44 to AmerisourceBergen Drug Corp for SUNOSI (sodium oxybate) 150 mg tablets in a quantity of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SUNOSI is a central...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SUNOSI 150 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,372.38. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGL8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count) on September 2, 2025, with a ceiling value of $1,028.71. This firm fixed-price, non-set-aside contract is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness in patients with narcolepsy and other sleep disorders. This procurement supports the Defense Health Agency's pharmaceutical supply needs for military healthcare systems. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, leverages its comprehensive IDC vehicle to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to federal healthcare programs. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill critical medical commodity requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/2/25 |